ADC Therapeutics (NYSE:ADCT) Stock Price Expected to Rise, Stephens Analyst Says
ADC Therapeutics (NYSE:ADCT – Free Report) had its price objective hoisted by Stephens from $6.00 to $8.00 in a research note released on Monday,Benzinga reports. Stephens currently has an overweight rating on the stock. Other equities research analysts also recently issued reports about the stock. Guggenheim reissued a “buy” rating and set a $10.00 price […]
ADC Therapeutics (NYSE:ADCT – Free Report) had its price objective hoisted by Stephens from $6.00 to $8.00 in a research note released on Monday,Benzinga reports. Stephens currently has an overweight rating on the stock. Other equities research analysts also recently issued reports about the stock. Guggenheim reissued a “buy” rating and set a $10.00 price […]
